Indietro
ABEVMY conc perf 100 mg/4ml (ec 03/26)
Medius AG
| Articolo | Carenza | Pharmacode | Prezzo | Cat. di dispensazione | Cat. di rimborso | |
|---|---|---|---|---|---|---|
ABEVMY conc perf 100 mg/4ml flac 4 mlAvosano Industrie Service AG | 1157632 | CHF 254.30 | Cat. A | SL / 10% |
Articoli alternativi senza carenza di approvvigionamento segnalata
| Articolo | Carenza | Pharmacode | Prezzo | Cat. di dispensazione | Cat. di rimborso | Relazione farmaceutica | |
|---|---|---|---|---|---|---|---|
AVASTIN conc perf 100 mg/4ml vial 4 mlAlloga AG | 2918877 | CHF 309.80 | Cat. A | SL / 10% | Equivalente | ||
MVASI conc perf 100 mg/4ml flac 4 mlAmgen Switzerland AG | 7775506 | CHF 254.30 | Cat. A | SL / 10% | Equivalente | ||
ZIRABEV conc perf 100 mg/4ml vial 4 mlPfizer AG | 7773044 | CHF 254.30 | Cat. A | SL / 10% | Equivalente | ||
BEVACIZUMAB Teva conc perf 100 mg/4ml flacMepha Pharma AG | 7803857 | CHF 254.30 | Cat. A | SL / 10% | Equivalente | ||
OYAVAS conc perf 100 mg/4ml flac 4 mlSpirig HealthCare AG | 7808005 | CHF 254.30 | Cat. A | SL / 10% | Equivalente | ||
VEGZELMA conc perf 100 mg/4ml flacAvosano Industrie Service AG | 1026568 | CHF 254.30 | Cat. A | SL / 10% | Equivalente | ||
AVASTIN conc perf 400 mg/16ml vial 16 mlAlloga AG | 2918914 | CHF 1136.85 | Cat. A | SL / 10% | Forma | ||
MVASI conc perf 400 mg/16ml flac 16 mlAmgen Switzerland AG | 7775507 | CHF 924.60 | Cat. A | SL / 10% | Forma | ||
ZIRABEV conc perf 400 mg/16ml vial 16 mlPfizer AG | 7773043 | CHF 924.60 | Cat. A | SL / 10% | Forma | ||
BEVACIZUMAB Teva conc perf 400 mg/16ml flacMepha Pharma AG | 7803858 | CHF 924.60 | Cat. A | SL / 10% | Forma |